Regular ArticleA Native Soluble Form of CTLA-4☆,☆☆
References (44)
- et al.
Human B8-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors
Immunity
(1994) - et al.
Binding stoichiometry of the cytotoxic lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules
J. Biol. Chem.
(1995) - et al.
Molecular cloning and expression of a receptor for human tumor necrosis factor
Cell
(1990) - et al.
The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms
Cell
(1989) - et al.
Cloning of the human and murine interleukin-7 receptors: Demonstration of a soluble form and homology to a new receptor superfamily
Cell
(1990) Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
Cell
(1992)- et al.
CTLA-4 can function as a negative regulator of T cell activation
Immunity
(1994) - et al.
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
Immunity
(1995) - et al.
A new member of the immunoglobulin superfamily—CTLA-4
Nature
(1987) - et al.
A differential molecular biology search for genes preferentially expressed in functional T lymphocytes: The CTLA genes
Immunol. Rev.
(1988)
Regulation of CTLA-4 expression during T cell activation
J. Immunol.
(1996)
Activated T cells can induce high levels of CTLA-4 expression on B cells
J. Immunol.
(1995)
Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains
Eur. J. Immunol.
(1988)
CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location
J. Immunol.
(1991)
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation
J. Exp. Med.
(1991)
CTLA-4 is a second receptor for the B cell activation antigen B7
J. Exp. Med.
(1991)
Coexpression and functional cooperativity of CTLA-4 and CD28 on activated T lymphocytes
J. Exp. Med.
(1992)
CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production
J. Immunol.
(1992)
CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production and generation of CTL
J. Immunol.
(1995)
T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo
Proc. Natl. Acad. Sci. USA
(1992)
Induction of alloantigen-specific hyporesponsiveness in human T-lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1
J. Exp. Med.
(1993)
Cited by (219)
Soluble CTLA-4 attenuates T cell activation and modulates anti-tumor immunity
2024, Molecular TherapyNews on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors
2022, Seminars in Cancer Biology
- ☆
This work was supported in part by grants from the Vince Lombardi Cancer Research Foundation (No. 225-25 to M.K.O.) and from the Department of Cardiothoracic Surgery.
- ☆☆
The nucleotide and predicted amino acid sequence data reported in this paper have been submitted to the GenBank sequence database and have been assigned the following accession numbers: Mouse sCTLA-4, U90270; Rat sCTLA-4, U90271; Rat intron/exon boundaries, AF012711, AF012712, and AF012713; Human sCTLA-4, U90273.
- 3
To whom correspondence should be addressed at Transplant Research Laboratory, St. Luke's Medical Center, 2900 W. Oklahoma Ave., Milwaukee, WI 53215. Fax: (414)-647-1292. E-mail: [email protected].
Copyright © 2000 Academic Press. All rights reserved.